Cypress Wealth Services LLC Makes New Investment in The Ensign Group, Inc. $ENSG

Cypress Wealth Services LLC purchased a new stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 8,658 shares of the company’s stock, valued at approximately $1,508,000.

A number of other institutional investors also recently modified their holdings of ENSG. Wasatch Advisors LP lifted its stake in shares of The Ensign Group by 6.0% in the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock worth $548,961,000 after buying an additional 199,983 shares during the last quarter. Baillie Gifford & Co. grew its stake in The Ensign Group by 96.2% in the 3rd quarter. Baillie Gifford & Co. now owns 2,818,609 shares of the company’s stock valued at $486,971,000 after buying an additional 1,382,035 shares during the last quarter. Capital Research Global Investors raised its holdings in The Ensign Group by 7.2% in the 3rd quarter. Capital Research Global Investors now owns 2,016,101 shares of the company’s stock worth $348,322,000 after acquiring an additional 136,260 shares during the period. Dimensional Fund Advisors LP raised its holdings in The Ensign Group by 0.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,085,380 shares of the company’s stock worth $187,516,000 after acquiring an additional 8,272 shares during the period. Finally, Norges Bank acquired a new position in The Ensign Group during the 2nd quarter worth $105,400,000. Institutional investors own 96.12% of the company’s stock.

Insider Transactions at The Ensign Group

In other news, Director Daren Shaw sold 1,000 shares of The Ensign Group stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $213.43, for a total transaction of $213,430.00. Following the sale, the director owned 23,726 shares of the company’s stock, valued at approximately $5,063,840.18. This trade represents a 4.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $171.54, for a total value of $120,078.00. Following the sale, the director owned 23,552 shares in the company, valued at approximately $4,040,110.08. This represents a 2.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 17,073 shares of company stock worth $3,333,390. 3.90% of the stock is currently owned by company insiders.

The Ensign Group Price Performance

Shares of The Ensign Group stock opened at $200.66 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.42 and a quick ratio of 1.42. The company has a market cap of $11.62 billion, a PE ratio of 34.36, a price-to-earnings-growth ratio of 1.97 and a beta of 0.83. The firm has a fifty day moving average price of $199.37 and a two-hundred day moving average price of $185.18. The Ensign Group, Inc. has a fifty-two week low of $118.73 and a fifty-two week high of $218.00.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.07. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The business’s revenue was up 20.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.49 EPS. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. Analysts expect that The Ensign Group, Inc. will post 5.59 EPS for the current year.

The Ensign Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date is Tuesday, March 31st. The Ensign Group’s payout ratio is currently 4.45%.

Analysts Set New Price Targets

A number of research firms have issued reports on ENSG. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a report on Thursday, January 22nd. Truist Financial set a $215.00 price objective on The Ensign Group and gave the stock a “hold” rating in a research report on Friday, February 6th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Zacks Research raised The Ensign Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 26th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $204.60.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.